1,10-Phenanthroline → 6-(1-phenyl-ethoxy)-4-(toluene-3-sulfonyl)-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine
反応式
Br[C:2]1[CH:3]=[CH:4][C:5]2[O:6][CH2:7][CH2:8][N:9]([S:12]([C:15]3[CH:16]=[C:17]([CH3:21])[CH:18]=[CH:19][CH:20]=3)(=[O:14])=[O:13])[C:10]=2[N:11]=1.N1[C:35]2[C:26](=[CH:27][CH:28]=[C:29]3[C:34]=2N=CC=C3)[CH:25]=[CH:24]C=1.C([O-])([O-])=[O:37].[Cs+].[Cs+]>[Cu]I>[C:26]1([CH:25]([O:37][C:2]2[CH:3]=[CH:4][C:5]3[O:6][CH2:7][CH2:8][N:9]([S:12]([C:15]4[CH:16]=[C:17]([CH3:21])[CH:18]=[CH:19][CH:20]=4)(=[O:14])=[O:13])[C:10]=3[N:11]=2)[CH3:24])[CH:35]=[CH:34][CH:29]=[CH:28][CH:27]=1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
反応条件
- 温度
- 130 °C
実験手順
To 6-bromo-4-(toluene-3-sulfonyl)-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine (50 mg, 140 mmol) in (d,l)-1-phenylethanol (400 μL) was added CuI (15 mg, 79 mmol), 1,10-phenanthroline (15 mg, 83 mmol), and Cs2CO3 (70 mg, 210 mmol). The resulting mixture was heated to 130° C. for 2 hours. Next, the reaction mixture was cooled to room temperature and quenched with a small amount of water, then extracted with ethyl acetate. The aqueous phase was discarded and the organic phase was concentrated under reduced pressure. The resulting residue was purified by HPLC to give 6-(1-phenyl-ethoxy)-4-(toluene-3-sulfonyl)-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine. LCMS(ESI): calc. C22H22N2O4S=410; obs. M+H=411.
後処理
- temperatureNext, the reaction mixture was cooled to room temperature
- customquenched with a small amount of water
- extractionextracted with ethyl acetate
- concentrationthe organic phase was concentrated under reduced pressure
- customThe resulting residue was purified by HPLC
出典と根拠
- ORDレコード
- ord-f7c3f415a1a4476a966d0098dc98af1a
- 出典データセット
- uspto-grants-2016_07
- 特許番号
- US09394315B2
反応ノート
読み込み中…